References
- Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, et al. 2020. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respir Med. 106192. doi:https://doi.org/10.1016/j.rmed.2020.106192.
- Antic D, Wright KE, Yong Kang C. 1992. Maturation of hantaan virus glycoproteins G1 and G2. Virology. 189(1):324–328. doi:https://doi.org/10.1016/0042-6822(92)90709-X.
- Avšič Županc T, Korva M. 2014. Hantavirus Infections. In: Emerging infectious diseases: clinical case studies. Academic Press; p. 25–36. ISBN 9780124201095
- Avšič-Županc T, Saksida A, Korva M. 2019. Hantavirus infections. Clin. Microbiol. Infect. 21:e6–e16. doi:https://doi.org/10.1111/1469-0691.12291.
- Barrera S, Martínez S, Tique-Salleg V, Miranda J, Guzmán C, Mattar S. 2015. Seroprevalence of Hantavirus, Rickettsia y Chikungunya in the indigenous population of Tuchín, Córdoba | seroprevalencia de Hantavirus, Rickettsia y Chikungunya en población indígena del municipio de Tuchín, Córdoba. Infectio. 19(2):75–82. doi:https://doi.org/10.1016/j.infect.2015.02.001.
- Bi Z, Formenty PBH, Roth CE. 2008. Hantavirus infection: a review and global update. J Infect Dev Ctries. 2(1): doi:https://doi.org/10.3855/jidc.317.
- Bisen PS, Raghuvanshi R. 2011. Emerging epidemics: management and Control. 375–399.
- Borish L, Williams J, Johnson S, Mascali JJ, Miller R, Rosenwasser LJ. 1992. Anti-inflammatory effects of nedocromil sodium: inhibition of alveolar macrophage function. Clinical Experimental Allergy. 22(11):984–990. doi:https://doi.org/10.1111/j.1365-2222.1992.tb03025.x.
- Brocato RL, Hooper JW. 2019. Progress on the prevention and treatment of hantavirus disease. Viruses. 11(7):610. doi:https://doi.org/10.3390/v11070610.
- Campbell ID, Humphries MJ. 2011. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 3(3):a004994–a004994. doi:https://doi.org/10.1101/cshperspect.a004994.
- Christos Watson D, Sargianou M, Papa A, Chra P, Starakis I, Panos G. 2014. Critical reviews in microbiology epidemiology of hantavirus infections in humans: a comprehensive, global overview epidemiology of hantavirus infections in humans: a comprehensive, global overview. Ioannis Starakis Georg. Panos Crit Rev Microbiol Crit Rev Microbiol. doi:https://doi.org/10.3109/1040841X.2013.783555
- Clement J, Maes P, Van Ranst M. 2014. Hemorrhagic fever with renal syndrome in the new, and hantavirus pulmonary syndrome in the old world: paradi(se)gm lost or regained? Virus Res. 187:55–58. doi:https://doi.org/10.1016/j.virusres.2013.12.036
- Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, et al. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 330(14):949–955. doi:https://doi.org/10.1056/NEJM199404073301401.
- Dvorscak L, Czuchlewski DR. 2014. Successful triage of suspected hantavirus cardiopulmonary syndrome by peripheral blood smear review: a decade of experience in an endemic region. Am J Clin Pathol. 142(2):196–201. doi:https://doi.org/10.1309/AJCPNFVWG46NUHED.
- Eckerle I, Lenk M, Ulrich RG. 2014. More novel hantaviruses and diversifying reservoir hosts - Time for development of reservoir-derived cell culture models? Viruses. 6(3):951–967. doi:https://doi.org/10.3390/v6030951.
- Engler O, Klingström J, Aliyev E, Niederhauser C, Fontana S, Strasser M, Portmann J, Signer J, Bankoul S, Frey F, et al. 2013. Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity. Eurosurveillance. 18(50). doi:https://doi.org/10.2807/1560-7917.ES2013.18.50.20660.
- Ermonval M, Baychelier F, Tordo N. 2016. What do we know about how hantaviruses interact with their different hosts? Viruses. 8(8):223. doi:https://doi.org/10.3390/v8080223.
- Figueiredo LTM, Enria DA, Enria DA, Enria DA, . Hantaviruses and cardiopulmonary syndrome in South America. Virus Res. 2014 doi: https://doi.org/10.1016/j.virusres.2014.01.015 187 43–54.
- Gorain B, Choudhury H, Molugulu N, Athawale RB, Kesharwani P. 2020. Fighting strategies against the novel coronavirus pandemic: impact on global economy. Front Public Heal. 8:800. doi:https://doi.org/10.3389/FPUBH.2020.606129
- Gött P, Zöller L, Darai G, Bautz EKF. 1997. A major antigenic domain of Hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes. 14(1):31–40. doi:https://doi.org/10.1023/A:1007983306341.
- Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, Levy H. 1996. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med. 24(2):252–258. doi:https://doi.org/10.1097/00003246-199602000-00012.
- Hantavirus Death in China Does Not Mean the Start of Another Coronavirus-like Outbreak Available online: ( accessed on 2021 Mar 7. https://www.newsweek.com/hantavirus-death-china-coronavirus-outbreak-1494099.
- Hart CA, Bennett M. 1999. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect. 1(14):1229–1237. doi:https://doi.org/10.1016/S1286-4579(99)00238-5.
- Hepojoki J, Strandin T, Lankinen H, Vaheri A. 2012. Hantavirus structure - Molecular interactions behind the scene. J Gen Virol. 93(8):1631–1644. doi:https://doi.org/10.1099/vir.0.042218-0.
- Hepojoki J, Strandin T, Vaheri A, Lankinen H. 2010. Interactions and oligomerization of hantavirus glycoproteins. J Virol. 84(1):227–242. doi:https://doi.org/10.1128/jvi.00481-09.
- Heyman P, Vaheri A, Lundkvist Å, Avsic-Zupanc T. 2009. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther. 7(2):205–217. doi:https://doi.org/10.1586/14787210.7.2.205.
- Hjelle B, Torres-Pérez F. 2010. Hantaviruses in the Americas and their role as emerging pathogens. Viruses. 2(12):2559–2586. doi:https://doi.org/10.3390/v2122559.
- Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN, et al. 1991. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 164(6):1119–1127. doi:https://doi.org/10.1093/infdis/164.6.1119.
- Huiskonen JT, Hepojoki J, Laurinmaki P, Vaheri A, Lankinen H, Butcher SJ, Grunewald K. 2010. Electron cryotomography of tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol. 84(10):4889–4897. doi:https://doi.org/10.1128/jvi.00057-10.
- Jiang H, Du H, Wang LM, Wang PZ, Bai XF. 2016. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture. Front Cell Infect Microbiol. 6(1).
- Jin M, Park J, Lee S, Park B, Shin J, Song KJ, Ahn TI, Hwang SY, Ahn BY, Ahn K. 2002. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology. 294(1):60–69. doi:https://doi.org/10.1006/viro.2001.1303.
- Jonsson CB, Figueiredo LTM, Vapalahti O. 2010. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 23:412–441.
- Kallio ER, Klingström J, Gustafsson E, Manni T, Vaheri A, Henttonen H, Vapalahti O, Lundkvist Å. 2006. Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol. 87(8):2127–2134. doi:https://doi.org/10.1099/vir.0.81643-0.
- Kamrud KI, Schmaljohn CS. 1994. Expression strategy of the M genome segment of Hantaan virus. Virus Res. 31(1):109–121. doi:https://doi.org/10.1016/0168-1702(94)90074-4.
- Kanerva M, Mustonen J, Vaheri A. 1998. Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol. 8(2):67–86. doi:https://doi.org/10.1002/(SICI)1099-1654(199804/06)8:2<67::AID-RMV217>3.0.CO;2-U.
- Kitsutani PT, Denton RW, Fritz CL, Murray RA, Todd RL, Pape WJ, Frampton JW, Young JC, Khan AS, Peters CJ, et al. 1999. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis. 5(5):701–705. doi:https://doi.org/10.3201/eid0505.990512.
- Kucinskaite-Kodze I, Petraityte-Burneikiene R, Zvirbliene A, Hjelle B, Medina RA, Gedvilaite A, Razanskiene A, Schmidt-Chanasit J, Mertens M, Padula P, et al. 2011. Characterization of monoclonal antibodies against hantavirus nucleocapsid protein and their use for immunohistochemistry on rodent and human samples. Arch Virol. 156(3):443–456. doi:https://doi.org/10.1007/s00705-010-0879-6.
- Lednicky JA. 2003. Hantaviruses: a short review. Arch Pathol Lab Med. 127(1):30–5.
- Lee HW, French GR, Lee PW, Baek LJ, Tsuchiya K, Foulke RS. 1981. Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am J Trop Med Hyg. 30: doi:https://doi.org/10.4269/ajtmh.1981.30.477.
- Li Z, Bai X, Bian H. 2002. Serologic diagnosis of hantaan virus infection based on a peptide antigen. Clin Chem. 48(4):645–647. doi:https://doi.org/10.1093/clinchem/48.4.645.
- Lindkvist M, Näslund J, Ahlm C, Bucht G. 2008. Cross-reactive and serospecific epitopes of nucleocapsid proteins of three hantaviruses: prospects for new diagnostic tools. Virus Res. 137(1):97–105. doi:https://doi.org/10.1016/j.virusres.2008.06.003.
- Löber C, Anheier B, Lindow S, Klenk HD, Feldmann H. 2001. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology. 289(2):224–229. doi:https://doi.org/10.1006/viro.2001.1171.
- Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Överby AK, Pettersson RF, Helenius A. 2010. Entry of bunyaviruses into mammalian cells. Cell Host Microbe. 7(6):488–499. doi:https://doi.org/10.1016/j.chom.2010.05.007.
- Mackow ER, Gavrilovskaya IN. 2009. Hantavirus regulation of endothelial cell functions. Thromb Haemost. 12(2009):1030–1041.
- MacNeil A, Nichol ST, Spiropoulou CF. 2011. Hantavirus pulmonary syndrome. Virus Res. 162(1–2):138–147. doi:https://doi.org/10.1016/j.virusres.2011.09.017.
- Markotić A, Hensley L, Daddario K, Spik K, Anderson K, Schmaljohn C. 2007. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll Antropol. 31(4):1159–1167.
- Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, Padula PJ. 2005. Person-to-person transmission of Andes virus. Emerg Infect Dis. 11(12):1848–1853. doi:https://doi.org/10.3201/eid1112.050501.
- Martinez-Valdebenito C, Calvo M, Vial C, Mansilla R, Marco C, Palma RE, Vial PA, Valdivieso F, Mertz G, Ferrés M. 2014. Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg Infect Dis. 20(10):1637–1644. doi:https://doi.org/10.3201/eid2010.140353.
- Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA. 2006. Diagnosis and treatment of new world hantavirus infections. Curr. Opin. Infect. Dis. 19(5):437–442. doi:https://doi.org/10.1097/01.qco.0000244048.38758.1f.
- Mills JN, Corneli A, Young JC, Garrison LE, Khan AS, Ksiazek TG. 2002. Hantavirus pulmonary syndrome–United States: updated recommendations for risk reduction. Centers for disease control and prevention. MMWR. Recomm Rep. v. 51, no. RR-9
- Mir MA, Panganiban AT. 2010. The triplet repeats of the Sin Nombre hantavirus 5ʹ untranslated region are sufficient in cis for Nucleocapsid-Mediated Translation Initiation. J Virol. 84(17):8937–8944. doi:https://doi.org/10.1128/jvi.02720-09.
- Mittler E, Dieterle ME, Kleinfelter LM, Slough MM, Chandran K, Jangra RK. 2019. Hantavirus entry: perspectives and recent advances. In Advances in Virus Research. 104:185–224. ISBN 9780128183946.
- Muranyi W, Bahr U, Zeier M, Van Der Woude FJ. 2005. Hantavirus infection. J Am Soc Nephrol. 16(12):3669–3679. doi:https://doi.org/10.1681/ASN.2005050561.
- Nuzum EO, Rossi CA, Stephenson EH, LeDuc JW. 1988. Aerosol transmission of Hantaan and related viruses to laboratory rats. Am J Trop Med Hyg. 38(3):636–640. doi:https://doi.org/10.4269/ajtmh.1988.38.636.
- Osadebe LU. 2012. Hantavirus pulmonary syndrome in visitors to a national park - Yosemite Valley, California, 2012. Morb Mortal Wkly Rep. 61(46):952.
- Pandey D, Kesharwani P, Jain D. 2019. Entrapment of drug-sorbate complex in submicron emulsion: a potential approach to improve antimicrobial activity in bacterial corneal infection. J Drug Deliv Sci Technol. 49: doi:https://doi.org/10.1016/j.jddst.2018.12.006.
- Ramanathan HN, Chung D-H, Plane SJ, Sztul E, Chu Y-K, Guttieri MC, McDowell M, Ali G, Jonsson CB. 2007. Dynein-Dependent transport of the hantaan virus nucleocapsid protein to the Endoplasmic Reticulum-Golgi intermediate compartment. J Virol. 81(16):8634–8647. doi:https://doi.org/10.1128/jvi.00418-07.
- Ramanathan HN, Jonsson CB. 2008. New and old world hantaviruses differentially utilize host cytoskeletal components during their life cycles. Virology. 374(1):138–150. doi:https://doi.org/10.1016/j.virol.2007.12.030.
- Sargianou M, Watson DC, Chra P, Papa A, Starakis I, Gogos C, Panos G. 2012. Hantavirus infections for the clinician: from case presentation to diagnosis and treatment. Crit Rev Microbiol. 38(4):317–329. doi:https://doi.org/10.3109/1040841X.2012.673553.
- Schmaljohn C, Hjelle B. 1997. Hantaviruses: a global disease problem. Emerg Infect Dis. 3(2):95–104. doi:https://doi.org/10.3201/eid0302.970202.
- Schmaljohn CS, Dalrymple JM. 1983. Analysis of hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology. 131(2):482–491. doi:https://doi.org/10.1016/0042-6822(83)90514-7.
- Schmauohn CS, Schmauohn AL, Dalrymple JM. 1987. Hantaan virus MRNA: coding strategy, nucleotide sequence, and gene order. Virology. 157(1):31–39. doi:https://doi.org/10.1016/0042-6822(87)90310-2.
- Sinisalo M, Vapalahti O, Ekblom-Kullberg S, Laine O, Mäkelä S, Rintala H, Vaheri A. 2010. Headache and low platelets in a patient with acute leukemia. J Clin Virol. 48(3):159–161. doi:https://doi.org/10.1016/j.jcv.2010.02.015.
- Sironen T, Plyusnin A. 2011. Bunyaviridae: molecular and cellular biology. Bunyaviridae Mol Cell Biol. Norfolk, UK : Caister Academic Press
- Spiropoulou CF. 2000. Hantavirus maturation. Curr Top Microbiol Immunol. 256:33–46.
- Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA, Peters CJ, Rollin PE. 2001. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75(13):6070–6085. doi:https://doi.org/10.1128/jvi.75.13.6070-6085.2001.
- Szabó R. 2017. Antiviral therapy and prevention against hantavirus infections. Acta Virol. 61(1):3–12. doi:https://doi.org/10.4149/av_2017_01_3.
- Takagi J, Springer TA. 2002. Integrin activation and structural rearrangement. Immunol Rev. 186(1):141–163. doi:https://doi.org/10.1034/j.1600-065X.2002.18613.x.
- Vaheri A. Hantaviruses. In: Encyclopedia of virology.2008. Volume 5, ELSEVIER/ Dr. Brian W.J. Mahy. ISBN 9780123744104
- Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, Mäkelä S, Mustonen J. 2013. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol. 11(8):539–550. doi:https://doi.org/10.1038/nrmicro3066.
- Van Loock F, Thomas I, Clement J, Ghoos S, Colson P. 1999. A Case‐Control study after a hantavirus infection outbreak in the South of Belgium: who is at risk? Clin Infect Dis. 28(4):834–839. doi:https://doi.org/10.1086/515196.
- Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A. 2003. Hantavirus infections in Europe. Lancet Infect Dis. 3(10): doi:https://doi.org/10.1016/s1473-3099(03)00774-6.
- Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G. 2014. Epidemiology of hantavirus infections in humans: a comprehensive, global overview. Crit. Rev. Microbiol. 40(3):261–272. doi:https://doi.org/10.3109/1040841X.2013.783555.
- WHO Coronavirus disease. 2019. World Heal. Organ. 2020(2019):2633. doi:https://doi.org/10.1001/jama.2020.2633.
- Witkowski PT, Drexler JF, Kallies R, Ličková M, Bokorová S, Mananga GD, Szemes T, Leroy EM, Krüger DH, Drosten C, et al. 2016. Phylogenetic analysis of a newfound bat-borne hantavirus supports a laurasiatherian host association for ancestral mammalian hantaviruses. Infect Genet Evol. 41:113–119. doi:https://doi.org/10.1016/j.meegid.2016.03.036
- Yanagihara R, Silverman DJ. 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol. 111(3–4):281–286. doi:https://doi.org/10.1007/BF01311063.
- Zeier M, Handermann M, Bahr U, Rensch B, Müller S, Kehm R, Muranyi W, Darai G. 2005. New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention - A review. Virus Genes. 30(2):157–180. doi:https://doi.org/10.1007/s11262-004-5625-2.